S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0060
0.00 (0.00%)
Aug 12, 2026, 5:22 PM CET
S2Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 16.89 | 22.33 | 8.45 | 8.93 | 11.5 | |
Revenue Growth | -24.37% | 164.25% | -5.37% | -22.35% | -59.92% |
Cost of Revenue | 2.4 | 1.11 | 2.11 | 2.6 | 4.08 |
Gross Profit | 14.49 | 21.22 | 6.34 | 6.33 | 7.42 |
Selling, General & Admin | 15.45 | 14.99 | 19.14 | 31.54 | 25.54 |
Depreciation & Amortization Expenses | 1.28 | 1.31 | 1.73 | 1.92 | 1.49 |
Other Operating Expenses | 0.43 | 0.09 | 0.73 | 0.56 | 0.22 |
Total Operating Expenses | 17.16 | 16.39 | 21.6 | 34.02 | 27.26 |
Operating Income | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
Interest Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | -0.01 | -0.02 | -7.44 | -1.77 | -0.24 |
Other Non-Operating Income (Expense) | -7.42 | 0 | - | - | - |
Total Non-Operating Income (Expense) | -7.43 | -0.02 | -7.44 | -1.77 | -0.24 |
Pretax Income | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income to Common | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 857 | 560 | 121 | 24 | 15 |
Shares Outstanding (Diluted) | 857 | 560 | 121 | 24 | 15 |
Shares Change | 53.03% | 360.86% | 411.02% | 60.30% | 26.41% |
EPS (Basic) | -0.02 | 0.01 | -0.08 | -0.90 | -1.33 |
EPS (Diluted) | -0.02 | 0.01 | -0.08 | -0.90 | -1.33 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | 0.68 | 5.03 | -16.52 | -28.34 | -19.85 |
Free Cash Flow Growth | -86.56% | - | - | - | - |
Free Cash Flow Per Share | 0.00 | 0.01 | -0.14 | -1.19 | -1.34 |
Gross Margin | 85.80% | 95.02% | 75.00% | 70.89% | 64.54% |
Operating Margin | -15.77% | 21.62% | -180.61% | -310.03% | -172.47% |
Profit Margin | -59.76% | 21.54% | -268.69% | -329.82% | -174.59% |
FCF Margin | 4.00% | 22.53% | -195.47% | -317.31% | -172.62% |
EBITDA | -1.39 | 6.14 | -13.53 | -25.77 | -18.34 |
EBITDA Margin | -8.22% | 27.48% | -160.09% | -288.56% | -159.48% |
EBIT | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
EBIT Margin | -15.77% | 21.62% | -180.61% | -310.03% | -172.47% |